ReviewCancer drug resistance (Alhambra, Calif.)2019

Molecular mechanisms of enzalutamide resistance in prostate cancer.

Eliot B Blatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.